The outcome of a multidisciplinary approach incorporating neoadjuvant chemoradiotherapy with S1 for resectable pancreatic ductal adenocarcinoma.

Masaru MatsumuraGoro HondaKeigo TaniSatoshi NemotoYusuke OmeSara HayakawaMizuka SuzukiShin-Ichiro HoriguchiMasataka KikuyamaYasuji Seyama

Published in: Annals of gastroenterological surgery (2022)

A multidisciplinary approach incorporating S1-NACRT for resectable pancreatic ductal adenocarcinoma demonstrated acceptable tolerability and good local control and resulted in comparable survival benefits.

Keyphrases

locally advanced
rectal cancer
squamous cell carcinoma
radiation therapy
quality improvement
open label
liver metastases
free survival
randomized controlled trial
clinical trial